Page results
-
A team of clinician scientists at UCLH have identified the factors which predict full hearing recovery, with the strongest predictor being treatment with steroids within seven days of a sudden drop in hearing.
-
Pfizer Limited, in agreement with the Medicines Healthcare products Regulatory Agency (MHRA), has withdrawn the product, while a review of the benefits and risks is carried out.
-
Outcome of National Institute for Health and Care Excellence (NICE) Technology Appraisal for Exagamglogene autotemcel (Exa-cel) for treating transfusion- dependent beta thalassaemia [ID4015] in individuals 12 years and over.
-
This page offers information and support for patients with hearing loss.
-
This leaflet has been written by the Huntington’s team at the National Hospital for Neurology and Neurosurgery. It is intended for patients (and their families or carers) who are under the care…
-
This page is for people who may need a RIG and their carers.
File results
-
FOI/2020/0002 - Surgical tools left inside patients
-
FOI/2019/514 Benchmarking tool
-
FOI/2019/516 TMS and SCS protocols, guidelines and treatment pathways
-
FOI/2019/524 UCLH Phase 5 contractors
-
FOI/2019/597 In-house stop smoking service for patients
-
FOI/2020/0007 - Radical radiotherapy to the breast or chestwall
-
FOI/2020/0026 - Total number of DoLS referrals
-
FOI/2020/0008 - Venous thromboembolism treatment protocol and volumes
-
FOI/2023/0236 - Proton Beam Therapy Centre
-
FOI/2020/0004 - Referrals to foodbanks